Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R41/R42 Clinical Trials Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website Save this grant

Next deadline: Jun 25, 2024 (Letter of inquiry)

Later deadlines: Jul 25, 2024 (Full proposal)

Grant amount: Up to US $9,400,000

Fields of work: Addiction & Substance Use Disorders Pharmacology Drug Safety Artificial Intelligence (AI)

Applicant type: For-Profit Business

Funding uses: Research

Location of project: United States

Location of residency: United States


NOTE: All applications are due by 5:00 PM local time of applicant organization.

The purpose of this funding opportunity is to develop artificial intelligence tools and experimental assays to identify new pharmacotherapeutics with lower toxicity and higher efficacy for substance use disorders (SUD) Areas of interest include but are not limited to:

  • Development of AI tools to identify potential target combinations, design new molecules, conduct virtual preclinical studies to predict efficacy and toxicity, and model in vitro and in vivo polypharmacology
  • Development of assays to assess the effects of compounds on multiple targets or functions

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Your history with this funder
No saved opportunities from this funder yet
Save this opportunity to add notes...
Save this opportunity to add contacts...

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed January 30, 2024 and last updated January 30, 2024